NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹216 Cr | ₹311 Cr | ₹340 Cr | ₹351 Cr | ₹51 Cr |
What is the latest Net Current Assets ratio of NECTAR LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹340 Cr |
| Mar2022 | ₹351 Cr |
| Mar2021 | ₹51 Cr |
How is Net Current Assets of NECTAR LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹216 Cr | -30.53 | |
| Mar2024 | ₹311 Cr | -8.59 | |
| Mar2023 | ₹340 Cr | -3.07 | |
| Mar2022 | ₹351 Cr | 582.45 | |
| Mar2021 | ₹51 Cr | - | |
Compare Net Current Assets of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹202.5 Cr | -3.1% | -9.5% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -3.1% |
-9.5% |
-42.2% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses